Noninvasive Ultra Low Intensity Light Photodynamic Treatment of Glioblastoma with Drug Augmentation: LoGlo PDT Regimen
2024

New Noninvasive Treatment for Glioblastoma Using Light and Drugs

publication Evidence: moderate

Author Information

Author(s): Kast Richard E., Kast Anton P., Arnhold Jürgen, Capanni Felix, Sanabria Laura N. Milla, Bader Nicolas, Vieira Bruno Marques, Alfieri Alex, Karpel-Massler Georg, da Silva Erasmo Barros Jr.

Primary Institution: IIAIGC Study Center

Hypothesis

Can low-intensity light combined with drug augmentation improve photodynamic treatment for glioblastoma?

Conclusion

The LoGlo PDT regimen may provide a more effective and noninvasive treatment for glioblastoma by using low-intensity light and repurposed drugs.

Supporting Evidence

  • Low-intensity light can be delivered noninvasively to the scalp for effective treatment.
  • Three common drugs can enhance the effectiveness of photodynamic therapy for glioblastoma.
  • Current treatments for glioblastoma have high mortality rates, indicating a need for new approaches.

Takeaway

This study suggests that shining low-intensity light on the head for a long time, along with certain medicines, can help treat a serious brain cancer called glioblastoma.

Methodology

The study analyzes existing data on light penetration and drug effects to propose a new treatment regimen for glioblastoma.

Limitations

There are uncertainties regarding light penetration and the variability in patient responses to treatment.

Digital Object Identifier (DOI)

10.3390/brainsci14121164

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication